Sun-Novo Pharma Committed to Strategic Positioning in Innovative Drug Development

Deep News
Jul 09

On July 9th, Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. responded to investor inquiries via an interactive platform, stating the company is resolutely committed to positioning itself within the innovative drug sector.

By aligning with its own strategic plans and development capabilities, the firm continues to focus on cutting-edge directions in biotechnology research and development, striving to become a comprehensive pharmaceutical enterprise with capabilities in innovative drug R&D and clinical translation.

Should any merger, acquisition, or restructuring plans arise, they will be disclosed promptly in accordance with relevant regulations, including the Shanghai Stock Exchange Listing Rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10